A Study to Assess the Safety, Tolerability and Effectiveness of MT-0814 for the Treatment of Age-related Macular Degeneration

Inclusion Criteria: * Must agree to sign informed consent form, and to comply with protocol requirements, including study visits. * Must have clear optic media in the study eye that is capable of producing high-quality fundus images. Exclusion Criteria: * Has active CNV due to causes other than AMD in the study eye. * Has retinal vascular disease or retinal degeneration other than AMD in the study eye. * Has had intraocular surgery, cataract surgery or LASIK surgery on the study eye within 90 days prior to the study. * Has had yttrium aluminum garnet (YAG) laser capsulotomy on the study eye within 30 days prior to the study. * Has active inflammation, infection, or other severe ocular disease in either eye. * Has aphakia in the study eye. * Has uncontrolled glaucoma or a history of previous glaucoma filter surgery in either eye. * Is a contact lens wearer and is unable to discontinue their use in both eyes for the duration of the study. * Has a serious allergy to, or experienced a prior significant adverse reaction to fluorescein angiography (FA) or indocyanine green angiography (ICGA). * Has participated in any other clinical trial and/or has taken any investigational drug or product within 90 days prior to the study. Other protocol-defined inclusion/exclusion criteria could apply.